Phenotypic Microarray for Diagnosis of Cancer

Case ID:
C11683
Disclosure Date:
9/20/2011

Invention novelty: High Throughput Screening of pancreatic cancer cells by developing a phenotypic microarray

 

Value Proposition: The market for cancer diagnostics is ever-expanding as the focus of global research on cancer reached its peak in the past five years. The use of microarrays as an ideal diagnostic tool for cancer detection is being realized by clinical laboratories around the world. While most of the conventional microarrays rely on genomic or proteomic data, this invention exploits the morphological aberrations of neoplastic cells for its detection and quantitation. Phenotypic microarray (PM) technology is a relatively nascent concept which can be used for several applications, particularly in cytological studies. PM arrays provide existing microarray companies additional avenues for expanding the portfolio of their current products and services. 

Technical Details: Johns Hopkins University researchers have developed a method and device for the rapid detection/diagnosis of neoplastic pancreatic tumors and its metastasis into the liver at a single cell resolution. The system consists of a phenotypic microarray of eleven arbitrary human pancreatic cancer and normal cell lines which analyzes up to 300 biophysical and morphometric parameters for each cell which are based on various cellular and nuclear phenotypes. This is done in order to realize High Definition Cell Morphology (HDCP) which ensures high fidelity output for a given cell sample. The parameters have been observed by employing techniques such as tissue imaging, immunostaining techniques and were quantified using a customized High-Throughput Cell Phenotyping (htCP) MATLAB code developed exclusively by the inventors.

 

Looking for Partners: To develop & commercialize the technology as

-       Diagnostic tool for cancer detection.

-       High Throughput Screening Systems (HTSS) for cytological studies.

-       Alternative/Complementary technology platform for Genomic/Proteomic Microarrays

 

Stage of Development: Prototype

 

Data Availability: Optical Microscopy, Immunofluorescence Staining, MATLAB

       

Patent Status: Granted US Patent 8,934,698 and 9,435,738

 

Associated Publication: Sci Rep. 2015; 5: 18437

Patent Information:
Title App Type Country Serial No. Patent No. File Date Issued Date Expire Date Patent Status
A novel method for improved staging/diagnosis of cancerous tissues that will also enable better matching for treatment ORD: Ordinary Utility United States 13/530,772 8,934,698 6/22/2012 1/13/2015 6/22/2032 Granted
A novel method for improved staging/diagnosis of cancerous tissues that will also enable better matching for treatment DIV: Divisional United States 14/560,759 9,435,738 12/4/2014 9/6/2016 6/22/2032 Granted
Inventors:
Category(s):
Get custom alerts for techs in these categories/from these inventors:
For Information, Contact:
Vera Sampels
vsampel2@jhu.edu
410-614-0300
Save This Technology:
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum